FDAFDA · Food and drugs·Recall number D-0220-2024
Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53
Published January 17, 2024 · Recall initiated: November 17, 2023
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Container: powder may leak out of the pouch
What to do
Voluntary: Firm initiated · Letter
Recall details
- Brand
- VIGABATRIN
- Manufacturer
- InvaGen Pharmaceuticals, Inc.
- Distributor
- Nationwide within the United States
- Lot
- Lot #: NB301030, Exp. Date 03/31/2025
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Sell products like this?
Recalert watches your whole catalog for recalls like this one, automatically.